Violeta Yu

5.3k total citations · 1 hit paper
29 papers, 4.4k citations indexed

About

Violeta Yu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Violeta Yu has authored 29 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Violeta Yu's work include Ion channel regulation and function (7 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Violeta Yu is often cited by papers focused on Ion channel regulation and function (7 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Violeta Yu collaborates with scholars based in United States, Canada and Switzerland. Violeta Yu's co-authors include Donald W. Nicholson, Ting-Ting Yamin, Ambereen Ali, John P. Vaillancourt, Douglas K. Miller, Marc Labelle, Michel Gallant, Mark E. Smulson, Patrick R. Griffin and Nancy A. Thornberry and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Neuron.

In The Last Decade

Violeta Yu

29 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1995 3.6k citations Donald W. Nicholson, Ambereen Ali et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Violeta Yu United States	15	3.2k	774	768	483	352	29	4.4k
Ambereen Ali United States	10	3.3k 1.1×	789 1.0×	884 1.2×	522 1.1×	417 1.2×	13	4.5k
Tsung-I Peng Taiwan	7	3.5k 1.1×	585 0.8×	556 0.7×	429 0.9×	258 0.7×	7	4.7k
Razvan Lapadat United States	9	2.3k 0.7×	685 0.9×	623 0.8×	543 1.1×	306 0.9×	22	4.1k
Jongsun Park South Korea	35	4.0k 1.3×	657 0.8×	591 0.8×	632 1.3×	445 1.3×	126	5.7k
Solange Desagher France	18	4.0k 1.3×	645 0.8×	672 0.9×	447 0.9×	540 1.5×	23	5.1k
Elizabeth A. Slee United Kingdom	17	3.6k 1.1×	755 1.0×	1.1k 1.4×	543 1.1×	469 1.3×	28	4.8k
John C. Reed United States	12	3.8k 1.2×	789 1.0×	1.0k 1.3×	637 1.3×	361 1.0×	13	5.0k
Joan Gil Spain	38	2.9k 0.9×	557 0.7×	918 1.2×	509 1.1×	364 1.0×	110	4.9k
Jean‐Luc Vayssière France	24	3.6k 1.2×	768 1.0×	651 0.8×	514 1.1×	308 0.9×	37	5.5k
Ajay Rana United States	33	2.2k 0.7×	479 0.6×	998 1.3×	568 1.2×	339 1.0×	97	3.7k

Countries citing papers authored by Violeta Yu

Since Specialization

Citations

This map shows the geographic impact of Violeta Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Yu more than expected).

Fields of papers citing papers by Violeta Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Yu. The network helps show where Violeta Yu may publish in the future.

Co-authorship network of co-authors of Violeta Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Yu. A scholar is included among the top collaborators of Violeta Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Yu. Violeta Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Jesse D., et al.. (2025). KCTD20 suppression mitigates excitotoxicity in tauopathy patient organoids. Neuron. 113(8). 1169–1189.e7. 1 indexed citations

Lai, Jesse D., Naomi S. Sta Maria, Russell E. Jacobs, et al.. (2024). KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury. Cell stem cell. 31(4). 519–536.e8. 22 indexed citations

Milgram, Benjamin C., R. Foti, Thomas Kornecook, et al.. (2022). Discovery of pyridyl urea sulfonamide inhibitors of NaV1.7. Bioorganic & Medicinal Chemistry Letters. 73. 128892–128892. 1 indexed citations

Zhang, Hongkang, Bryan D. Moyer, Violeta Yu, et al.. (2020). Correlation of Optical and Automated Patch Clamp Electrophysiology for Identification of NaV1.7 Inhibitors. SLAS DISCOVERY. 25(5). 434–446. 4 indexed citations

Boezio, Alessandro A., Kristin L. Andrews, Margaret Y. Chu‐Moyer, et al.. (2018). 1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of NaV1.7 inhibition. Bioorganic & Medicinal Chemistry Letters. 28(11). 2103–2108. 8 indexed citations

Moyer, Bryan D., Justin K. Murray, Joseph Ligutti, et al.. (2018). Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V. PLoS ONE. 13(5). e0196791–e0196791. 35 indexed citations

Sparling, Brian A., Jessica Able, Howard Bregman, et al.. (2016). Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na_V1.7 inhibitors. MedChemComm. 8(4). 744–754. 4 indexed citations

Simard, Jeffrey R., Matthew Plant, Renee Emkey, & Violeta Yu. (2013). Development and Implementation of a High-Throughput AlphaLISA Assay for Identifying Inhibitors of EZH2 Methyltransferase. Assay and Drug Development Technologies. 11(3). 152–162. 16 indexed citations

Drew, Allison E., Violeta Yu, Paul S. Andrews, et al.. (2011). Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor. SLAS DISCOVERY. 16(2). 164–173. 5 indexed citations

10.

Liu, Liqin, Gordon Moody, Jeanne Pistillo, et al.. (2011). Abstract 1975: Discovery of a potent and selective Jak2 inhibitor that suppresses GM-CSF-induced STAT5 phosphorylation and Erythropoietin-induced reticulocytosis in vivo. Cancer Research. 71(8_Supplement). 1975–1975. 1 indexed citations

11.

Han, Chun-Ya, Youping Wang, David Powers, et al.. (2009). Small molecules with potent osteogenic-inducing activity in osteoblast cells. Bioorganic & Medicinal Chemistry Letters. 19(5). 1442–1445. 25 indexed citations

12.

Kurzeja, Robert J., et al.. (2008). Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology. Analytical Biochemistry. 384(2). 213–223. 63 indexed citations

13.

Chen, Ning, Roland W. Bürli, Susana Neira, et al.. (2008). Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 18(14). 4137–4141. 6 indexed citations

14.

Kunz, Roxanne K., Dawei Zhang, Andrew S. Tasker, et al.. (2008). Discovery of amido-benzisoxazoles as potent c-Kit inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5115–5117. 10 indexed citations

15.

Yu, Violeta, Yanyan Tudor, Clarence Hale, et al.. (2007). High Capacity Homogeneous Non-Radioactive Cortisol Detection Assays for Human 11 β -Hydroxysteroid Dehydrogenase Type 1. Assay and Drug Development Technologies. 5(1). 105–116. 1 indexed citations

16.

Ross, Sandra L., Teresa C. Chen, Violeta Yu, et al.. (2006). High-Content Screening Analysis of the p38 Pathway: Profiling of Structurally Related p38 α Kinase Inhibitors Using Cell-Based Assays. Assay and Drug Development Technologies. 4(4). 397–409. 15 indexed citations

17.

Tamayo, Nuria, David Powers, Yanyan Tudor, et al.. (2005). Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2409–2413. 40 indexed citations

18.

Sugamori, Kim S., Sharon Y. Wong, Andrea Gaedigk, et al.. (2003). Generation and Functional Characterization of Arylamine N-Acetyltransferase Nat1/Nat2Double-Knockout Mice. Molecular Pharmacology. 64(1). 170–179. 62 indexed citations

19.

Tagari, Philip, Kevin Rowan, Violeta Yu, et al.. (1995). Epitope-labeled Soluble Human Interleukin-5 (IL-5) Receptors. Journal of Biological Chemistry. 270(49). 29236–29243. 14 indexed citations

20.

Vaillancourt, John P., Ambereen Ali, Douglas K. Miller, et al.. (1995). Molecular Cloning and Pro-apoptotic Activity of ICErelII and ICErelIII, Members of the ICE/CED-3 Family of Cysteine Proteases. Journal of Biological Chemistry. 270(26). 15870–15876. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact